Skip to main content

Welcome to RNAi News

Premium

Welcome to RNAi News, the weekly newsletter on technology for gene silencing. RNAi News is the latest in the family of professional-focus news services brought to you by the editors of GenomeWeb.

Each week, beginning the first week of September, subscribers of RNAi News will receive breaking news, features, and inside reporting on RNA interference and other methods of gene silencing.

The newsletter will offer complete coverage on the latest research innovations, and how they affect your work with RNAi, as well as the companies competing to make and sell RNAi and other gene-silencing technologies. We will also provide news on the shifting sands of intellectual property surrounding RNAi and short interfering RNA, or siRNA; and will deliver in-depth interviews with the pioneers who are shaping this fast-moving technology.

The news will be delivered to your in-box directly in PDF format, and will be posted on the password-only RNAi News website.

If you are looking to make your mark with RNAi technology, you can’t afford to be without this valuable information source.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.